APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer research"
DOI: 10.1158/0008-5472.can-16-3389
Abstract: The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like APOBEC3A and APOBEC3B have emerged as key mutation drivers in cancer. Here, we show that APOBEC3A and APOBEC3B activities impose a unique type of replication stress by… read more here.
Keywords: apobec3a apobec3b; apobec3b activities; atr inhibition; cancer ... See more keywords